Immune mechanisms linking obesity and preeclampsia

Biomolecules

Volumn 5, Issue 4, 2015, Pages 3142-3176

  Spradley, Frank T ^a   Palei, Ana C ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Adipose; Antibody; Endothelin; Hypertension; Lymphocyte; Pregnancy

Indexed keywords

ANGIOGENIC FACTOR; ANGIOTENSIN 1 RECEPTOR; C REACTIVE PROTEIN; INTERLEUKIN 17; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; VASCULOTROPIN; CYTOKINE; ENDOTHELIN 1;

BODY MASS; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HELPER CELL; HISTOCOMPATIBILITY COMPLEX; HUMAN; HYPERGLYCEMIA; HYPERLEPTINEMIA; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISCHEMIA; MACROPHAGE ACTIVATION; MATERNAL HYPERTENSION; NATURAL KILLER CELL; NONHUMAN; OBESITY; PLACENTAL ISCHEMIA; PREECLAMPSIA; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR; ANIMAL; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; PRE-ECLAMPSIA; PREGNANCY;

ANIMALS; CYTOKINES; ENDOTHELIN-1; FEMALE; HUMANS; OBESITY; PRE-ECLAMPSIA; PREGNANCY;

EID: 84971353384     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5043142     Document Type: Review

References (216)

1. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the american college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet. Gynecol. 2013, 122, 1122–1131
2. Vogel, J.P.; Lee, A.C.; Souza, J.P. Maternal morbidity and preterm birth in 22 low- and middle-income countries: A secondary analysis of the who global survey dataset. BMC Pregnancy Childbirth 2014, doi:10.1186/1471-2393-14-56
3. Khan, K.S.; Wojdyla, D.; Say, L.; Gulmezoglu, A.M.; van Look, P.F. Who analysis of causes of maternal death: A systematic review. Lancet 2006, 367, 1066–1074
4. Steegers, E.A.; von Dadelszen, P.; Duvekot, J.J.; Pijnenborg, R. Pre-eclampsia. Lancet 2010, 376, 631–644
5. Hytten, F. Blood volume changes in normal pregnancy. Clin. Haematol.1985, 14, 601–612
6. Osol, G.; Moore, L.G. Maternal uterine vascular remodeling during pregnancy. Microcirculation 2014, 21, 38–47
7. Whitley, G.S.; Cartwright, J.E. Cellular and molecular regulation of spiral artery remodelling: Lessons from the cardiovascular field. Placenta 2010, 31, 465–474
8. Phillips, J.K.; Vance, A.M.; Raj, R.S.; Mandala, M.; Linder, E.A.; Gokina, N.I. Impact of experimental diabetes on the maternal uterine vascular remodeling during rat pregnancy. Reprod. Sci. 2012, 19, 322–331
9. Sheppard, S.J.; Khalil, R.A. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Cardiovasc. Hematol. Disord. Drug Targets 2010, 10, 33–52
10. Roberts, J.M. Pathophysiology of ischemic placental disease. Semin. Perinatol.2014, 38, 139–145
11. Ashton, S.V.; Whitley, G.S.; Dash, P.R.; Wareing, M.; Crocker, I.P.; Baker, P.N.; Cartwright, J.E. Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through fas/fasl interactions. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 102–108
12. Hunkapiller, N.M.; Gasperowicz, M.; Kapidzic, M.; Plaks, V.; Maltepe, E.; Kitajewski, J.; Cross, J.C.; Fisher, S.J. A role for notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia. Development 2011, 138, 2987–2998
13. Lyall, F.; Robson, S.C.; Bulmer, J.N. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: Relationship to clinical outcome. Hypertension 2013, 62, 1046–1054
14. Hofmann, A.P.; Gerber, S.A.; Croy, B.A. Uterine natural killer cells pace early development of mouse decidua basalis. Mol. Hum. Reprod.2014, 20, 66–76
15. Aplin, J.D.; Haigh, T.; Jones, C.J.; Church, H.J.; Vicovac, L. Development of cytotrophoblast columns from explanted first-trimester human placental villi: Role of fibronectin and integrin alpha5beta1. Biol. Reprod. 1999, 60, 828–838
16. Salomon, C.; Yee, S.W.; Mitchell, M.D.; Rice, G.E. The possible role of extravillous trophoblastderived exosomes on the uterine spiral arterial remodeling under both normal and pathological conditions. Biomed. Res. Int.2014, doi:10.1155/2014/693157
17. Robson, A.; Harris, L.K.; Innes, B.A.; Lash, G.E.; Aljunaidy, M.M.; Aplin, J.D.; Baker, P.N.; Robson, S.C.; Bulmer, J.N. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J. 2012, 26, 4876–4885
18. Renaud, S.J.; Postovit, L.M.; Macdonald-Goodfellow, S.K.; McDonald, G.T.; Caldwell, J.D.; Graham, C.H. Activated macrophages inhibit human cytotrophoblast invasiveness in vitro. Biol. Reprod. 2005, 73, 237–243
19. LaMarca, B.; Cornelius, D.; Wallace, K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology 2013, 28, 225–233
20. Tal, R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol. Reprod. 2012, doi:10.1095/biolreprod.112.102723
21. Iriyama, T.; Wang, W.; Parchim, N.F.; Song, A.; Blackwell, S.C.; Sibai, B.M.; Kellems, R.E.; Xia, Y. Hypoxia-independent upregulation of placental hypoxia inducible factor-1alpha gene expression contributes to the pathogenesis of preeclampsia. Hypertension 2015, 65, 1307–1315
22. Losonczy, G.; Brown, G.; Venuto, R.C. Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits. Am. J. Med. Sci. 1992, 303, 233–240
23. Gilbert, J.S.; Ryan, M.J.; LaMarca, B.B.; Sedeek, M.; Murphy, S.R.; Granger, J.P. Pathophysiology of hypertension during preeclampsia: Linking placental ischemia with endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2008, 294, H541–H550
24. Hussein, W.; Lafayette, R.A. Renal function in normal and disordered pregnancy. Curr. Opin. Nephrol. Hypertens. 2014, 23, 46–53
25. Sholook, M.M.; Gilbert, J.S.; Sedeek, M.H.; Huang, M.; Hester, R.L.; Granger, J.P. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2080–H2084
26. Ananth, C.V.; Keyes, K.M.; Wapner, R.J. Pre-eclampsia rates in the united states, 1980–2010: Age-period-cohort analysis. BMJ 2013, doi:10.1136/bmj.f6564
27. Mitchell, S.; Shaw, D. The worldwide epidemic of female obesity. Best Pract. Res. Clin. Obstet. Gynaecol. 2015, 29, 289–299
28. Alexandra, P.; Vassilios, B.; Alexandra, V.; George, K.; Vassiliki, L.; Chryssa, B. Population-based trends of pregnancy outcome in obese mothers: What has changed over 15 years. Obesity 2011, 19, 1861–1865
29. Popkin, B.M.; Slining, M.M. New dynamics in global obesity facing low- and middle-income countries. Obes. Rev. 2013, 14, S11–S20
30. Flegal, K.M.; Carroll, M.D.; Kit, B.K.; Ogden, C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012, 307, 491–497
31. Mbah, A.K.; Kornosky, J.L.; Kristensen, S.; August, E.M.; Alio, A.P.; Marty, P.J.; Belogolovkin, V.; Bruder, K.; Salihu, H.M. Super-obesity and risk for early and late pre-eclampsia. BJOG 2010, 117, 997–1004
32. Calder, P.C.; Ahluwalia, N.; Brouns, F.; Buetler, T.; Clement, K.; Cunningham, K.; Esposito, K.; Jonsson, L.S.; Kolb, H.; Lansink, M., et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nut. 2011, 106, S5–S78
33. Romeo, G.R.; Lee, J.; Shoelson, S.E. Metabolic syndrome, insulin resistance, and roles of inflammation—Mechanisms and therapeutic targets. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 1771–1776
34. Womack, J.; Tien, P.C.; Feldman, J.; Shin, J.H.; Fennie, K.; Anastos, K.; Cohen, M.H.; Bacon, M.C.; Minkoff, H. Obesity and immune cell counts in women. Metabolism 2007, 56, 998–1004
35. Van Beek, L.; Lips, M.A.; Visser, A.; Pijl, H.; Ioan-Facsinay, A.; Toes, R.; Berends, F.J.; van Dijk, K.W.; Koning, F.; van Harmelen, V. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism 2014, 63, 492–501
36. Gonzalez, F.; Rote, N.S.; Minium, J.; O’Leary V, B.; Kirwan, J.P. Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity 2007, 15, 2436–2444
37. Singer, K.; Maley, N.; Mergian, T.; DelProposto, J.; Cho, K.W.; Zamarron, B.F.; Martinez-Santibanez, G.; Geletka, L.; Muir, L.; Wachowiak, P.; et al. Differences in hematopoietic stem cells contribute to sexually dimorphic inflammatory responses to high fat diet induced obesity. J. Biol. Chem. 2015, doi:10.1074/jbc.M114.634568
38. Patel, A.R.; Hui, H.; Kuvin, J.T.; Pandian, N.G.; Karas, R.H. Modestly overweight women have vascular endothelial dysfunction. Clin. Cardiol. 2009, 32, 269–273
39. Cola, M.S.; Gava, A.L.; Meyrelles, S.S.; Vasquez, E.C. Endothelial dysfunction of resistance vessels in female apolipoprotein e-deficient mice. Lipids Health Dis. 2010, doi:10.1186/1476-511X-9-51
40. Meyrelles, S.S.; Peotta, V.A.; Pereira, T.M.; Vasquez, E.C. Endothelial dysfunction in the apolipoprotein e-deficient mouse: Insights into the influence of diet, gender and aging. Lipids Health Dis. 2011, doi:10.1186/1476-511X-10-211
41. Ge, J.; Wang, J.; Xue, D.; Zhu, Z.; Chen, Z.; Li, X.; Su, D.; Du, J. Why does a high-fat diet induce preeclampsia-like symptoms in pregnant rats. Neural Regen. Res. 2013, 8, 1872–1880
42. Stewart, F.M.; Freeman, D.J.; Ramsay, J.E.; Greer, I.A.; Caslake, M.; Ferrell, W.R. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J. Clin. Endocrinol. Metab. 2007, 92, 969–975
43. Hayward, C.E.; Cowley, E.J.; Mills, T.A.; Sibley, C.P.; Wareing, M. Maternal obesity impairs specific regulatory pathways in human myometrial arteries. Biol. Reprod. 2014, doi:10.1095/biolreprod.113.112623
44. Saftlas, A.F.; Levine, R.J.; Klebanoff, M.A.; Martz, K.L.; Ewell, M.G.; Morris, C.D.; Sibai, B.M. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am. J. Epidemiol. 2003, 157, 1108–1114
45. Robillard, P.Y.; Hulsey, T.C.; Alexander, G.R.; Keenan, A.; de Caunes, F.; Papiernik, E. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J. Reprod. Immunol. 1993, 24, 1–12
46. Robillard, P.Y.; Hulsey, T.C.; Perianin, J.; Janky, E.; Miri, E.H.; Papiernik, E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994, 344, 973–975
47. Robertson, S.A.; Ingman, W.V.; O’Leary, S.; Sharkey, D.J.; Tremellen, K.P. Transforming growth factor beta—A mediator of immune deviation in seminal plasma. J. Reprod. Immunol. 2002, 57, 109–128
48. Aye, I.L.; Lager, S.; Ramirez, V.I.; Gaccioli, F.; Dudley, D.J.; Jansson, T.; Powell, T.L. Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol. Reprod.2014, doi:10.1095/biolreprod.113.116186
49. Saben, J.; Lindsey, F.; Zhong, Y.; Thakali, K.; Badger, T.M.; Andres, A.; Gomez-Acevedo, H.; Shankar, K. Maternal obesity is associated with a lipotoxic placental environment. Placenta 2014, 35, 171–177
50. Roberts, K.A.; Riley, S.C.; Reynolds, R.M.; Barr, S.; Evans, M.; Statham, A.; Hor, K.; Jabbour, H.N.; Norman, J.E.; Denison, F.C. Placental structure and inflammation in pregnancies associated with obesity. Placenta 2011, 32, 247–254
51. Hayes, E.K.; Tessier, D.R.; Percival, M.E.; Holloway, A.C.; Petrik, J.J.; Gruslin, A.; Raha, S. Trophoblast invasion and blood vessel remodeling are altered in a rat model of lifelong maternal obesity. Reprod Sci 2014, 21, 648–657
52. Hayes, E.K.; Lechowicz, A.; Petrik, J.J.; Storozhuk, Y.; Paez-Parent, S.; Dai, Q.; Samjoo, I.A.; Mansell, M.; Gruslin, A.; Holloway, A.C., et al. Adverse fetal and neonatal outcomes associated with a life-long high fat diet: Role of altered development of the placental vasculature. PloS ONE 2012, 7, e33370
53. Frias, A.E.; Morgan, T.K.; Evans, A.E.; Rasanen, J.; Oh, K.Y.; Thornburg, K.L.; Grove, K.L. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology 2011, 152, 2456–2464
54. Anim-Nyame, N.; Sooranna, S.R.; Steer, P.J.; Johnson, M.R. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod 2000, 15, 2033–2036
55. Zeron, H.M.; Solorio, V.J.G.; Diaz, P.M.N.; Alanis, A.G.; Benitez, J.G.S.; Garcia, V.D.; Briones, C.E.; Gutierrez, E.D. Hyperleptinemia as a prognostic factor for preeclampsia: A cohort study. Acta Med. 2012, 55, 165–171
56. Ning, Y.; Williams, M.A.; Muy-Rivera, M.; Leisenring, W.M.; Luthy, D.A. Relationship of maternal plasma leptin and risk of pre-eclampsia: A prospective study. J. Matern. Fetal Neonatal. Med. 2004, 15, 186–192
57. Papastefanou, I.; Samolis, S.; Panagopoulos, P.; Tagia, M.; Bale, C.; Kouskoukis, A.; Galazios, G. Correlation between maternal first trimester plasma leptin levels and birth weight among normotensive and preeclamptic women. J. Matern. Fetal Neonatal Med. 2010, 23, 1435–1443
58. Samolis, S.; Papastefanou, I.; Panagopoulos, P.; Galazios, G.; Kouskoukis, A.; Maroulis, G. Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies—Role of leptin as a marker of pre-eclampsia: A prospective casecontrol study. Gynecol. Endocrinol. 2010, 26, 338–343
59. Taylor, B.D.; Ness, R.B.; Olsen, J.; Hougaard, D.M.; Skogstrand, K.; Roberts, J.M.; Haggerty, C.L. Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women. Hypertension 2015, 65, 594–599
60. Iwagaki, S.; Yokoyama, Y.; Tang, L.; Takahashi, Y.; Nakagawa, Y.; Tamaya, T. Augmentation of leptin and hypoxia-inducible factor 1alpha mRNAs in the pre-eclamptic placenta. Gynecol. Endocrinol. 2004, 18, 263–268
61. Lepercq, J.; Guerre-Millo, M.; Andre, J.; Cauzac, M.; Hauguel-de Mouzon, S. Leptin: A potential marker of placental insufficiency. Gynecol. Obstet Investig. 2003, 55, 151–155
62. Mise, H.; Sagawa, N.; Matsumoto, T.; Yura, S.; Nanno, H.; Itoh, H.; Mori, T.; Masuzaki, H.; Hosoda, K.; Ogawa, Y., et al. Augmented placental production of leptin in preeclampsia: Possible involvement of placental hypoxia. J. Clin. Endocrinol. Metab. 1998, 83, 3225–3229
63. Tsai, P.J.; Davis, J.; Bryant-Greenwood, G. Systemic and placental leptin and its receptors in pregnancies associated with obesity. Reprod. Sci. 2015, 22, 189–197
64. Mazzucco, M.B.; Higa, R.; Capobianco, E.; Kurtz, M.; Jawerbaum, A.; White, V. Saturated fat-rich diet increases fetal lipids and modulates LPL and leptin receptor expression in rat placentas. J. Endocrinol. 2013, 217, 303–315
65. Bartha, J.L.; Romero-Carmona, R.; Escobar-Llompart, M.; Comino-Delgado, R. The relationships between leptin and inflammatory cytokines in women with pre-eclampsia. BJOG 2001, 108, 1272–1276
66. Palei, A.C.; Spradley, F.T.; Granger, J.P. Chronic hyperleptinemia results in the development of hypertension in pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2015, 38, R855–R861
67. Lappas, M.; Permezel, M.; Rice, G.E. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 2005, 146, 3334–3342
68. Saben, J.; Zhong, Y.; Gomez-Acevedo, H.; Thakali, K.M.; Borengasser, S.J.; Andres, A.; Shankar, K. Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: Role in maternal obesity. Am. J. Physiol. Endocrinol. Metab. 2013, 305, E1–E14
69. Faas, M.M.; Spaans, F.; de Vos, P. Monocytes and macrophages in pregnancy and pre-eclampsia. Front. Immunol.2014, doi:10.3389/fimmu.2014.00298
70. Wallace, A.E.; Fraser, R.; Cartwright, J.E. Extravillous trophoblast and decidual natural killer cells: A remodelling partnership. Hum. Reprod. Update 2012, 18, 458–471
71. Williams, P.J.; Bulmer, J.N.; Searle, R.F.; Innes, B.A.; Robson, S.C. Altered decidual leucocyte populations in the placental bed in pre-eclampsia and foetal growth restriction: A comparison with late normal pregnancy. Reproduction 2009, 138, 177–184
72. Bulmer, J.N.; Williams, P.J.; Lash, G.E. Immune cells in the placental bed. Int. J. Dev. Biol. 2010, 54, 281–294
73. Le Bouteiller, P.; Siewiera, J.; Casart, Y.; Aguerre-Girr, M.; el Costa, H.; Berrebi, A.; Tabiasco, J.; Jabrane-Ferrat, N. The human decidual NK-cell response to virus infection: What can we learn from circulating NK lymphocytes? J. Reprod. Immunol. 2011, 88, 170–175
74. Hanna, J.; Goldman-Wohl, D.; Hamani, Y.; Avraham, I.; Greenfield, C.; Natanson-Yaron, S.; Prus, D.; Cohen-Daniel, L.; Arnon, T.I.; Manaster, I., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006, 12, 1065–1074
75. El Costa, H.; Tabiasco, J.; Berrebi, A.; Parant, O.; Aguerre-Girr, M.; Piccinni, M.P.; le Bouteiller, P. Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors. J. Reprod. Immunol. 2009, 82, 142–147
76. Chazara, O.; Xiong, S.; Moffett, A. Maternal KIR and fetal HLA-C: A fine balance. J. Leukoc. Biol.2011, 90, 703–716
77. Harris, L.K. Review: Trophoblast-vascular cell interactions in early pregnancy: How to remodel a vessel. Placenta 2010, 31, S93–S98
78. Guimond, M.J.; Luross, J.A.; Wang, B.; Terhorst, C.; Danial, S.; Croy, B.A. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol. Reprod. 1997, 56, 169–179
79. Guimond, M.J.; Wang, B.; Croy, B.A. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J. Exp. Med. 1998, 187, 217–223
80. Ashkar, A.A.; di Santo, J.P.; Croy, B.A. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 2000, 192, 259–270
81. Monk, J.M.; Leonard, S.; McBey, B.A.; Croy, B.A. Induction of murine spiral artery modification by recombinant human interferon-gamma. Placenta 2005, 26, 835–838
82. Smith, S.D.; Dunk, C.E.; Aplin, J.D.; Harris, L.K.; Jones, R.L. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am. J. Pathol.2009, 174, 1959–1971
83. Hu, Y.; Dutz, J.P.; MacCalman, C.D.; Yong, P.; Tan, R.; von Dadelszen, P. Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: A role for IFN-gamma. J. Immunol. 2006, 177, 8522–8530
84. Kalkunte, S.S.; Mselle, T.F.; Norris, W.E.; Wira, C.R.; Sentman, C.L.; Sharma, S. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J. Immunol. 2009, 182, 4085–4092
85. Saito, S.; Nishikawa, K.; Morii, T.; Enomoto, M.; Narita, N.; Motoyoshi, K.; Ichijo, M. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int. Immunol. 1993, 5, 559–563
86. Otun, H.A.; Lash, G.E.; Innes, B.A.; Bulmer, J.N.; Naruse, K.; Hannon, T.; Searle, R.F.; Robson, S.C. Effect of tumour necrosis factor-alpha in combination with interferon-gamma on first trimester extravillous trophoblast invasion. J. Reprod. Immunol. 2011, 88, 1–11
87. Jovanovic, M.; Stefanoska, I.; Radojcic, L.; Vicovac, L. Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. Reproduction 2010, 139, 789–798
88. Parker, V.J.; Solano, M.E.; Arck, P.C.; Douglas, A.J. Diet-induced obesity may affect the uterine immune environment in early-mid pregnancy, reducing NK-cell activity and potentially compromising uterine vascularization. Int. J. Obes.2014, 38, 766–774
89. Lynch, L.A.; O’Connell, J.M.; Kwasnik, A.K.; Cawood, T.J.; O’Farrelly, C.; O’Shea, D.B. Are natural killer cells protecting the metabolically healthy obese patient? Obesity 2009, 17, 601–605
90. Huebner, L.; Engeli, S.; Wrann, C.D.; Goudeva, L.; Laue, T.; Kielstein, H. Human NK cell subset functions are differentially affected by adipokines. PLoS ONE 2013, 8, e75703
91. Orlova, E.G.; Shirshev, S.V. Leptin as an immunocorrecting agent during normal pregnancy. Bull. Exp. Biol. Med. 2009, 148, 75–78
92. Wrann, C.D.; Laue, T.; Hubner, L.; Kuhlmann, S.; Jacobs, R.; Goudeva, L.; Nave, H. Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am. J. Physiol. Endocrinol. Metab. 2012, 302, E108–E116
93. Haas, P.; Straub, R.H.; Bedoui, S.; Nave, H. Peripheral but not central leptin treatment increases numbers of circulating NK cells, granulocytes and specific monocyte subpopulations in non-endotoxaemic lean and obese LEW-rats. Regul. Pept.2008, 151, 26–34
94. Lamas, B.; Goncalves-Mendes, N.; Nachat-Kappes, R.; Rossary, A.; Caldefie-Chezet, F.; Vasson, M.P.; Farges, M.C. Leptin modulates dose-dependently the metabolic and cytolytic activities of NK-92 cells. J. Cell Physiol. 2013, 228, 1202–1209
95. Nave, H.; Mueller, G.; Siegmund, B.; Jacobs, R.; Stroh, T.; Schueler, U.; Hopfe, M.; Behrendt, P.; Buchenauer, T.; Pabst, R., et al. Resistance of janus kinase-2 dependent leptin signaling in natural killer (NK) cells: A novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 2008, 149, 3370–3378
96. Zhao, Y.; Sun, R.; You, L.; Gao, C.; Tian, Z. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem. Biophys. Res. Commun. 2003, 300, 247–252
97. Gustafsson, C.; Mjosberg, J.; Matussek, A.; Geffers, R.; Matthiesen, L.; Berg, G.; Sharma, S.; Buer, J.; Ernerudh, J. Gene expression profiling of human decidual macrophages: Evidence for immunosuppressive phenotype. PLoS ONE 2008, 3, e2078
98. Singh, U.; Nicholson, G.; Urban, B.C.; Sargent, I.L.; Kishore, U.; Bernal, A.L. Immunological properties of human decidual macrophages—A possible role in intrauterine immunity. Reproduction 2005, 129, 631–637
99. Nagamatsu, T.; Schust, D.J. The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod. Sci. 2010, 17, 209–218
100. Abrahams, V.M.; Kim, Y.M.; Straszewski, S.L.; Romero, R.; Mor, G. Macrophages and apoptotic cell clearance during pregnancy. Am. J. Reprod. Immunol. 2004, 51, 275–282
101. Burk, M.R.; Troeger, C.; Brinkhaus, R.; Holzgreve, W.; Hahn, S. Severely reduced presence of tissue macrophages in the basal plate of pre-eclamptic placentae. Placenta 2001, 22, 309–316
102. Reister, F.; Frank, H.G.; Heyl, W.; Kosanke, G.; Huppertz, B.; Schroder, W.; Kaufmann, P.; Rath, W. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 1999, 20, 229–233
103. Schonkeren, D.; van der Hoorn, M.L.; Khedoe, P.; Swings, G.; van Beelen, E.; Claas, F.; van Kooten, C.; de Heer, E.; Scherjon, S. Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am. J. Pathol.2011, 178, 709–717
104. Hayashi, M.; Hoshimoto, K.; Ohkura, T.; Inaba, N. Increased levels of macrophage colony-stimulating factor in the placenta and blood in preeclampsia. Am. J. Reprod. Immunol. 2002, 47, 19–24
105. Katabuchi, H.; Yih, S.; Ohba, T.; Matsui, K.; Takahashi, K.; Takeya, M.; Okamura, H. Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Med. Electron. Microsc. 2003, 36, 253–262
106. Keelan, J.A.; Mitchell, M.D. Placental cytokines and preeclampsia. Front. Biosci.2007, 12, 2706–2727
107. Reister, F.; Frank, H.G.; Kingdom, J.C.; Heyl, W.; Kaufmann, P.; Rath, W.; Huppertz, B. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab. Investig. 2001, 81, 1143–1152
108. Pavlov, O.V.; Sheveleva, T.S.; Selkov, S.A. In vitro expression of vascular endothelial growth factor and its receptors by placental macrophages. Bull. Exp. Biol. Med. 2012, 153, 222–225
109. Prins, J.R.; Faas, M.M.; Melgert, B.N.; Huitema, S.; Timmer, A.; Hylkema, M.N.; Erwich, J.J. Altered expression of immune-associated genes in first-trimester human decidua of pregnancies later complicated with hypertension or foetal growth restriction. Placenta 2012, 33, 453–455
110. Melgert, B.N.; Spaans, F.; Borghuis, T.; Klok, P.A.; Groen, B.; Bolt, A.; de Vos, P.; van Pampus, M.G.; Wong, T.Y.; van Goor, H.; et al.Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS ONE 2012, 7, e45229
111. Nagamatsu, T.; Schust, D.J. The contribution of macrophages to normal and pathological pregnancies. Am. J. Reprod. Immunol. 2010, 63, 460–471
112. Lockwood, C.J.; Basar, M.; Kayisli, U.A.; Guzeloglu-Kayisli, O.; Murk, W.; Wang, J.; de Paz, N.; Shapiro, J.P.; Masch, R.J.; Semerci, N., et al. Interferon-gamma protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia. Am. J. Pathol. 2014, 184, 2549–2559
113. Mantovani, A.; Biswas, S.K.; Galdiero, M.R.; Sica, A.; Locati, M. Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 2013, 229, 176–185
114. Challier, J.C.; Basu, S.; Bintein, T.; Minium, J.; Hotmire, K.; Catalano, P.M.; Hauguel-de Mouzon, S. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008, 29, 274–281
115. Zhu, M.J.; Du, M.; Nathanielsz, P.W.; Ford, S.P. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta 2010, 31, 387–391
116. Farley, D.; Tejero, M.E.; Comuzzie, A.G.; Higgins, P.B.; Cox, L.; Werner, S.L.; Jenkins, S.L.; Li, C.; Choi, J.; Dick, E.J., Jr.; et al. Feto-placental adaptations to maternal obesity in the baboon. Placenta 2009, 30, 752–760
117. Benyo, D.F.; Smarason, A.; Redman, C.W.; Sims, C.; Conrad, K.P. Expression of inflammatory cytokines in placentas from women with preeclampsia. J. Clin. Endocrinol. Metab. 2001, 86, 2505–2512
118. Peracoli, M.T.; Bannwart, C.F.; Cristofalo, R.; Borges, V.T.; Costa, R.A.; Witkin, S.S.; Peracoli, J.C. Increased reactive oxygen species and tumor necrosis factor-alpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. Am. J. Reprod. Immunol. 2011, 66, 460–467
119. Basu, S.; Leahy, P.; Challier, J.C.; Minium, J.; Catalano, P.; Hauguel-de Mouzon, S. Molecular phenotype of monocytes at the maternal-fetal interface. Am. J. Obstet. Gynecol. 2011, 205, e261–e268
120. Staff, A.C.; Johnsen, G.M.; Dechend, R.; Redman, C.W. Preeclampsia and uteroplacental acute atherosis: Immune and inflammatory factors. J. Reprod. Immunol. 2014, 101–102, 120–126
121. Harsem, N.K.; Roald, B.; Braekke, K.; Staff, A.C. Acute atherosis in decidual tissue: Not associated with systemic oxidative stress in preeclampsia. Placenta 2007, 28, 958–964
122. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, C.A., Jr. A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature 1997, 388, 394–397
123. Han, G.M.; O’Neil-Andersen, N.J.; Zurier, R.B.; Lawrence, D.A. CD4+CD25HIGH T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell. Immunol. 2008, 253, 92–101
124. Su, H.; Longhi, M.S.; Wang, P.; Vergani, D.; Ma, Y. Human CD4+CD25(high)CD127 (low/neg) regulatory T cells. Methods Mol. Biol. 2012, 806, 287–299
125. Santner-Nanan, B.; Peek, M.J.; Khanam, R.; Richarts, L.; Zhu, E.; de St Groth, B.F.; Nanan, R. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J. Immunol. 2009, 183, 7023–7030
126. Granger, J.P.; LaMarca, B.B.; Cockrell, K.; Sedeek, M.; Balzi, C.; Chandler, D.; Bennett, W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol. Med. 2006, 122, 383–392
127. Tam Tam, K.B.; George, E.; Cockrell, K.; Arany, M.; Speed, J.; Martin, J.N., Jr.; Lamarca, B.; Granger, J.P. Endothelin type a receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am. J. Obstet. Gynecol. 2011, 204, e331–e334
128. Wallace, K.; Richards, S.; Dhillon, P.; Weimer, A.; Edholm, E.S.; Bengten, E.; Wilson, M.; Martin, J.N., Jr.; LaMarca, B. CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 2011, 57, 949–955
129. Wallace, K.; Novotny, S.; Heath, J.; Moseley, J.; Martin, J.N., Jr.; Owens, M.Y.; LaMarca, B. Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 303, R144–R149
130. Wallace, K.; Cornelius, D.C.; Scott, J.; Heath, J.; Moseley, J.; Chatman, K.; LaMarca, B. CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia. Hypertension 2014, 64, 1151–1158
131. Luppi, P.; Haluszczak, C.; Betters, D.; Richard, C.A.; Trucco, M.; DeLoia, J.A. Monocytes are progressively activated in the circulation of pregnant women. J. Leukoc. Biol.2002, 72, 874–884
132. Wallace, F.A.; Miles, E.A.; Evans, C.; Stock, T.E.; Yaqoob, P.; Calder, P.C. Dietary fatty acids influence the production of th1- but not th2-type cytokines. J. Leukoc. Biol.2001, 69, 449–457
133. Tao, S.Y.; Gallaher, M.; Roberts, J.M. [9-or]: Obese women who develop preeclampsia exhibit a different metabolic profile early in pregnancy compared to obese women with uncomplicated pregnancies. Pregnancy Hypertens. 2015, doi:10.1016/j.preghy.2014.10.013
134. Novotny, S.R.; Wallace, K.; Heath, J.; Moseley, J.; Dhillon, P.; Weimer, A.; Wallukat, G.; Herse, F.; Wenzel, K.; Martin, J.N., Jr.; et al. Activating autoantibodies to the angiotensin II type 1 receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302, R1197–R1201
135. Guzik, T.J.; Hoch, N.E.; Brown, K.A.; McCann, L.A.; Rahman, A.; Dikalov, S.; Goronzy, J.; Weyand, C.; Harrison, D.G. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 2007, 204, 2449–2460
136. De Miguel, C.; Das, S.; Lund, H.; Mattson, D.L. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298, R1136–R1142
137. De Miguel, C.; Lund, H.; Mattson, D.L. High dietary protein exacerbates hypertension and renal damage in Dahl ss rats by increasing infiltrating immune cells in the kidney. Hypertension 2011, 57, 269–274
138. Kim, C.H.; Vaziri, N.D. Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. Kidney Int. 2005, 67, 1462–1470
139. Gurantz, D.; Cowling, R.T.; Villarreal, F.J.; Greenberg, B.H. Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts. Circ. Res. 1999, 85, 272–279
140. LaMarca, B.; Wallukat, G.; Llinas, M.; Herse, F.; Dechend, R.; Granger, J.P. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 2008, 52, 1168–1172
141. LaMarca, B.D.; Gilbert, J.; Granger, J.P. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 2008, 51, 982–988
142. LaMarca, B.B.; Cockrell, K.; Sullivan, E.; Bennett, W.; Granger, J.P. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 2005, 46, 82–86
143. LaMarca, B.; Parrish, M.; Ray, L.F.; Murphy, S.R.; Roberts, L.; Glover, P.; Wallukat, G.; Wenzel, K.; Cockrell, K.; Martin, J.N., Jr.; et al. Hypertension in response to autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pregnant rats: Role of endothelin-1. Hypertension 2009, 54, 905–909
144. LaMarca, B.D.; Alexander, B.T.; Gilbert, J.S.; Ryan, M.J.; Sedeek, M.; Murphy, S.R.; Granger, J.P. Pathophysiology of hypertension in response to placental ischemia during pregnancy: A central role for endothelin? Gender Med. 2008, 5, S133–S138
145. Li, H.P.; Chen, X.; Li, M.Q. Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta. Int. J. Clin. Exp. Pathol. 2013, 6, 650–659
146. Moreno, R.; Sobotzik, J.M.; Schultz, C.; Schmitz, M.L. Specification of the NF-kappab transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucl. Acids Res. 2010, 38, 6029–6044
147. Abraham, E. Nuclear factor-kappaB and its role in sepsis-associated organ failure. J. Infect. Dis. 2003, 187, S364–S369
148. Schaefer-Graf, U.M.; Meitzner, K.; Ortega-Senovilla, H.; Graf, K.; Vetter, K.; Abou-Dakn, M.; Herrera, E. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet. Med. 2011, 28, 1053–1059
149. Bomba-Opon, D.; Wielgos, M.; Szymanska, M.; Bablok, L. Effects of free fatty acids on the course of gestational diabetes mellitus. Neuro Endocrinol. Lett. 2006, 27, 277–280
150. Weiss, J.L.; Malone, F.D.; Emig, D.; Ball, R.H.; Nyberg, D.A.; Comstock, C.H.; Saade, G.; Eddleman, K.; Carter, S.M.; Craigo, S.D., et al. Obesity, obstetric complications and cesarean delivery rate—A population-based screening study. Am. J. Obstet. Gynecol. 2004, 190, 1091–1097
151. Bryson, C.L.; Ioannou, G.N.; Rulyak, S.J.; Critchlow, C. Association between gestational diabetes and pregnancy-induced hypertension. Am. J. Epidemiol.2003, 158, 1148–1153
152. Desoye, G.; Hauguel-de Mouzon, S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 2007, 30, S120–S126
153. Xu, J.; Zhao, Y.H.; Chen, Y.P.; Yuan, X.L.; Wang, J.; Zhu, H.; Lu, C.M. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: A systematic review and meta-analysis. Sci. World J. 2014, 2014, Article ID 926932
154. Guermouche, B.; Yessoufou, A.; Soulimane, N.; Merzouk, H.; Moutairou, K.; Hichami, A.; Khan, N.A. N-3 fatty acids modulate t-cell calcium signaling in obese macrosomic rats. Obes. Res. 2004, 12, 1744–1753
155. Wu, C.L.; Wu, Q.Y.; Du, J.J.; Zeng, J.Y.; Li, T.T.; Xu, C.Q.; Sun, Y.H. Calcium-sensing receptor in the T lymphocyte enhanced the apoptosis and cytokine secretion in sepsis. Mol. Immunol.2015, 63, 337–342
156. Chan, J.; Mehta, S.; Bharrhan, S.; Chen, Y.; Achkar, J.M.; Casadevall, A.; Flynn, J. The role of B cells and humoral immunity in mycobacterium tuberculosis infection. Semin. Immunol.2014, 26, 588–600
157. Fettke, F.; Schumacher, A.; Costa, S.D.; Zenclussen, A.C. B cells: The old new players in reproductive immunology. Front. Immunol.2014, doi:10.3389/fimmu.2014.00285
158. Schwartz, R.H. Historical overview of immunological tolerance. Cold Spring Harb. Perspect. Biol. 2012, doi:10.1101/cshperspect.a006908
159. LaMarca, B.; Wallace, K.; Herse, F.; Wallukat, G.; Martin, J.N., Jr.; Weimer, A.; Dechend, R. Hypertension in response to placental ischemia during pregnancy: Role of B lymphocytes. Hypertension 2011, 57, 865–871
160. Brewer, J.; Liu, R.; Lu, Y.; Scott, J.; Wallace, K.; Wallukat, G.; Moseley, J.; Herse, F.; Dechend, R.; Martin, J.N., Jr.; et al. Endothelin-1, oxidative stress, and endogenous angiotensin II: Mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy. Hypertension 2013, 62, 886–892
161. LaMarca, B.; Wallace, K.; Granger, J. Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. Curr. Opin. Pharmacol. 2011, 11, 175–179
162. Sen, S.; Iyer, C.; Klebenov, D.; Histed, A.; Aviles, J.A.; Meydani, S.N. Obesity impairs cell-mediated immunity during the second trimester of pregnancy. Am. J. Obstet. Gynecol. 2013, 208, e131–e138
163. Arai, S.; Maehara, N.; Iwamura, Y.; Honda, S.; Nakashima, K.; Kai, T.; Ogishi, M.; Morita, K.; Kurokawa, J.; Mori, M., et al. Obesity-associated autoantibody production requires aim to retain the immunoglobulin m immune complex on follicular dendritic cells. Cell Rep. 2013, 3, 1187–1198
164. Muller-Fielitz, H.; Lau, M.; Johren, O.; Stellmacher, F.; Schwaninger, M.; Raasch, W. Blood pressure response to angiotensin II is enhanced in obese zucker rats and is attributed to an aldosterone-dependent mechanism. Br. J. Pharmacol.2012, 166, 2417–2429
165. Nielsen, S.; Halliwill, J.R.; Joyner, M.J.; Jensen, M.D. Vascular response to angiotensin II in upper body obesity. Hypertension 2004, 44, 435–441
166. Taylor, P.D.; Khan, I.Y.; Lakasing, L.; Dekou, V.; O’Brien-Coker, I.; Mallet, A.I.; Hanson, M.A.; Poston, L. Uterine artery function in pregnant rats fed a diet supplemented with animal lard. Exp. Physiol. 2003, 88, 389–398
167. Pelletier, M.; Micheletti, A.; Cassatella, M.A. Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells. J. Leukoc. Biol.2010, 88, 1163–1170
168. Shah, T.J.; Leik, C.E.; Walsh, S.W. Neutrophil infiltration and systemic vascular inflammation in obese women. Reprod. Sci.2010, 17, 116–124
169. Shukla, J.; Walsh, S.W. Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia. Reprod. Sci.2015, 22, 300–307
170. Nilsson, J.; Nilsson, L.M.; Chen, Y.W.; Molkentin, J.D.; Erlinge, D.; Gomez, M.F. High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 794–800
171. Barquiel, B.; Herranz, L.; Grande, C.; Castro-Dufourny, I.; Llaro, M.; Parra, P.; Burgos, M.A.; Pallardo, L.F. Body weight, weight gain and hyperglycaemia are associated with hypertensive disorders of pregnancy in women with gestational diabetes. Diabetes Metab. 2014, 40, 204–210
172. Gallos, I.D.; Sivakumar, K.; Kilby, M.D.; Coomarasamy, A.; Thangaratinam, S.; Vatish, M. Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: A meta-analysis. BJOG 2013, 120, 1321–1332
173. Rajasingam, D.; Seed, P.T.; Briley, A.L.; Shennan, A.H.; Poston, L. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women. Am. J. Obstet. Gynecol. 2009, 200, e391–e399
174. Leiva, A.; de Medina, C.D.; Salsoso, R.; Saez, T.; san Martin, S.; Abarzua, F.; Farias, M.; Guzman-Gutierrez, E.; Pardo, F.; Sobrevia, L. Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: Role of endothelial nitric oxide synthase and arginase II. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 2444–2453
175. Chyu, K.Y.; Lio, W.M.; Dimayuga, P.C.; Zhou, J.; Zhao, X.; Yano, J.; Trinidad, P.; Honjo, T.; Cercek, B.; Shah, P.K. Cholesterol lowering modulates t cell function in vivo and in vitro. PLoS ONE 2014, 9, e92095
176. Denison, F.C.; Roberts, K.A.; Barr, S.M.; Norman, J.E. Obesity, pregnancy, inflammation, and vascular function. Reproduction 2010, 140, 373–385
177. Pausova, Z.; Deslauriers, B.; Gaudet, D.; Tremblay, J.; Kotchen, T.A.; Larochelle, P.; Cowley, A.W.; Hamet, P. Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French canadians. Hypertension 2000, 36, 14–19
178. Di Marco, G.S.; Reuter, S.; Hillebrand, U.; Amler, S.; Konig, M.; Larger, E.; Oberleithner, H.; Brand, E.; Pavenstadt, H.; Brand, M. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. J. Am. Soc. Nephrol. 2009, 20, 2235–2245
179. Veron, D.; Villegas, G.; Aggarwal, P.K.; Bertuccio, C.; Jimenez, J.; Velazquez, H.; Reidy, K.; Abrahamson, D.R.; Moeckel, G.; Kashgarian, M., et al. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus. PLoS ONE 2012, 7, e40589
180. Maynard, S.E.; Min, J.Y.; Merchan, J.; Lim, K.H.; Li, J.; Mondal, S.; Libermann, T.A.; Morgan, J.P.; Sellke, F.W.; Stillman, I.E., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003, 111, 649–658
181. Levine, R.J.; Maynard, S.E.; Qian, C.; Lim, K.H.; England, L.J.; Yu, K.F.; Schisterman, E.F.; Thadhani, R.; Sachs, B.P.; Epstein, F.H., et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004, 350, 672–683
182. Huckle, W.R.; Roche, R.I. Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor. J. Cell. Biochem.2004, 93, 120–132
183. Wang, A.; Rana, S.; Karumanchi, S.A. Preeclampsia: The role of angiogenic factors in its pathogenesis. Physiology 2009, 24, 147–158
184. Spradley, F.T.; Palei, A.C.; Granger, J.P. Obese melanocortin-4 receptor-deficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy. Physiol. Rep.2013, 1, e00081
185. Warrington, J.P.; George, E.M.; Palei, A.C.; Spradley, F.T.; Granger, J.P. Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension 2013, 62, 666–673
186. Gilbert, J.S.; Babcock, S.A.; Granger, J.P. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble FMS-like tyrosine kinase-1 expression. Hypertension 2007, 50, 1142–1147
187. Gilbert, J.S.; Verzwyvelt, J.; Colson, D.; Arany, M.; Karumanchi, S.A.; Granger, J.P. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension 2010, 55, 380–385
188. Murphy, S.R.; LaMarca, B.B.; Parrish, M.; Cockrell, K.; Granger, J.P. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: Role of tumor necrosis factor-alpha. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304, R130–R135
189. Parrish, M.R.; Murphy, S.R.; Rutland, S.; Wallace, K.; Wenzel, K.; Wallukat, G.; Keiser, S.; Ray, L.F.; Dechend, R.; Martin, J.N., et al. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin ii type i receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am. J. Hypertens. 2010, 23, 911–916
190. Roberts, J.M.; Bodnar, L.M.; Patrick, T.E.; Powers, R.W. The role of obesity in preeclampsia. Pregnancy Hypertens. 2011, 1, 6–16
191. Bodnar, L.M.; Catov, J.M.; Klebanoff, M.A.; Ness, R.B.; Roberts, J.M. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007, 18, 234–239
192. Bodnar, L.M.; Ness, R.B.; Markovic, N.; Roberts, J.M. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann. Epidemiol.2005, 15, 475–482
193. Wolf, M.; Kettyle, E.; Sandler, L.; Ecker, J.L.; Roberts, J.; Thadhani, R. Obesity and preeclampsia: The potential role of inflammation. Obstet. Gynecol.2001, 98, 757–762
194. Zera, C.A.; Seely, E.W.; Wilkins-Haug, L.E.; Lim, K.H.; Parry, S.I.; McElrath, T.F. The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies. Am. J. Obstet. Gynecol. 2014, 211, e241–e247
195. Suwaki, N.; Masuyama, H.; Nakatsukasa, H.; Masumoto, A.; Sumida, Y.; Takamoto, N.; Hiramatrsu, Y. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia. Am. J. Obstet. Gynecol. 2006, 195, 1687–1692
196. Kohan, D.E.; Rossi, N.F.; Inscho, E.W.; Pollock, D.M. Regulation of blood pressure and salt homeostasis by endothelin. Physiol. Rev.2011, 91, 1–77
197. Nova, A.; Sibai, B.M.; Barton, J.R.; Mercer, B.M.; Mitchell, M.D. Maternal plasma level of endothelin is increased in preeclampsia. Am. J. Obstet. Gynecol 1991, 165, 724–727
198. Pollock, D.M. Dissecting the complex physiology of endothelin: New lessons from genetic models. Hypertension 2010, 56, 31–33
199. Alexander, B.T.; Rinewalt, A.N.; Cockrell, K.L.; Massey, M.B.; Bennett, W.A.; Granger, J.P. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001, 37, 485–489
200. Bridges, J.P.; Gilbert, J.S.; Colson, D.; Gilbert, S.A.; Dukes, M.P.; Ryan, M.J.; Granger, J.P. Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am. J. Hypertens. 2009, 22, 564–568
201. Murphy, S.R.; LaMarca, B.B.; Cockrell, K.; Granger, J.P. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 2010, 55, 394–398
202. Lankhorst, S.; Kappers, M.H.; van Esch, J.H.; Danser, A.H.; van den Meiracker, A.H. Hypertension during vascular endothelial growth factor inhibition: Focus on nitric oxide, endothelin-1, and oxidative stress. Antioxid. Redox Signal. 2014, 20, 135–145
203. Star, G.P.; Giovinazzo, M.; Lamoureux, E.; Langleben, D. Effects of vascular endothelial growth factor on endothelin-1 production by human lung microvascular endothelial cells in vitro. Life Sci. 2014, 118, 191–194
204. Murphy, S.R.; LaMarca, B.; Cockrell, K.; Arany, M.; Granger, J.P. L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302, R259–R263
205. Kuo, J.J.; Jones, O.B.; Hall, J.E. Inhibition of no synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 2001, 37, 670–676
206. Hurst, J.W.; Fuster, V.; Walsh, R.A.; Harrington, R.A. Hurst’s the heart. 13th ed.; McGraw-Hill: New York, NY, USA, 2011
207. Hall, J.E.; Granger, J.P.; do Carmo, J.M.; da Silva, A.A.; Dubinion, J.; George, E.; Hamza, S.; Speed, J.; Hall, M.E. Hypertension: Physiology and pathophysiology. Compr. Physiol. 2012, 2, 2393–2442
208. Trovati, M.; Doronzo, G.; Barale, C.; Vaccheris, C.; Russo, I.; Cavalot, F. Leptin and vascular smooth muscle cells. Curr. Pharm. Des.2013, 20, 625–634
209. Juan, C.C.; Chuang, T.Y.; Lien, C.C.; Lin, Y.J.; Huang, S.W.; Kwok, C.F.; Ho, L.T. Leptin increases endothelin type a receptor levels in vascular smooth muscle cells. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E481–E487
210. Adiarto, S.; Emoto, N.; Iwasa, N.; Yokoyama, M. Obesity-induced upregulation of myocardial endothelin-1 expression is mediated by leptin. Biochem. Biophys. Res. Commun. 2007, 353, 623–627
211. Quehenberger, P.; Exner, M.; Sunder-Plassmann, R.; Ruzicka, K.; Bieglmayer, C.; Endler, G.; Muellner, C.; Speiser, W.; Wagner, O. Leptin induces endothelin-1 in endothelial cells in vitro. Circul. Res. 2002, 90, 711–718
212. Da Silva, A.A.; Kuo, J.J.; Tallam, L.S.; Hall, J.E. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension 2004, 43, 383–387
213. Molvarec, A.; Szarka, A.; Walentin, S.; Beko, G.; Karadi, I.; Prohaszka, Z.; Rigo, J., Jr. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod. Biol. Endocrinol. 2011, doi:10.1186/1477-7827-9-124
214. Lisonkova, S.; Sabr, Y.; Mayer, C.; Young, C.; Skoll, A.; Joseph, K.S. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet. Gynecol.2014, 124, 771–781
215. Raymond, D.; Peterson, E. A critical review of early-onset and late-onset preeclampsia. Obstet. Gynecol. Surv. 2011, 66, 497–506
216. Verlohren, S.; Melchiorre, K.; Khalil, A.; Thilaganathan, B. Uterine artery doppler, birth weight and timing of onset of pre-eclampsia: Providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound Obstet. Gynecol. 2014, 44, 293–298.